BioRestorative Therapies Inc (BRTX) — Cash Flow Quality Index
Latest as of September 2023:
-0.25x
BioRestorative Therapies Inc (BRTX) has a Cash Flow Quality Index of -0.25x as of September 2023. Operating cash flow of $-1.18 Million is below net income of $4.77 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore BRTX operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-0.25x
Operating CF / Net Income
Operating Cash Flow
$-1.18 Million
USD
Net Income
$4.77 Million
USD
Data as of
Sep 2023
Most recent filing
Annual Cash Flow Quality Index for BioRestorative Therapies Inc (None–None)
Year-by-year earnings quality comparison for BioRestorative Therapies Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.